President Trump has a big deadline this week. He announced tariffs in April, suspended them, and plans to reimpose them ...

Orr Inbar, CEO and co-founder of QuantHealth, unpacks the growing frustration over drug prices and the misperceptions fueling distrust in the pharmaceutical industry. With clinical trials now more ...

Dr. Vinay Prasad is stepping down as the Food and Drug Administration’s top vaccine regulator after a brief tenure. A ...

The plan to steal the Mitchell Map from a sleepy small-town museum in Urbanna, Virginia, didn’t sound quite so ...

Have you ever wondered why people who nearly die often describe speeding toward supernatural light, or seeing their life flash before their eyes? You may have also heard about the powerful psychedelic ...

At the end of 2023, long-awaited news arrived in West Virginia and across the United States: overdose deaths were dropping.

Ultrapotent synthetics, mostly from China, are easy to smuggle and mix into heroin, recreational drugs and gray-market ...

U.S. investment in new treatments is often driven by market potential rather than medical necessity, deepening health ...

After Nabarun Dasgupta lost a close friend to an overdose, he dedicated himself to addiction research and trying to empower drug users with lifesaving information.

This “super-cartel” won’t just be a criminal syndicate trafficking migrants and drugs: It will operate more like a rogue state.

Galderma is a pure-play dermatology company, with a leadership position in the self-care segment of the market, with more than 90% of total sales paid by consumers out of pocket. Its long-term revenue ...

In April, 2025, Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, appeared on the US television show 60 Minutes and suggested that all diseases could be curable with the help of ...